BMPR1A and breast carcinoma: CTL and BMPR1a-cKO mice were i.p. injected with β-glucan 7 days prior to intratibial injection of the syngeneic MMTV-PyMT mammary carcinoma bone clone to seed bone metastases (Figure 5M).